The European healthcare technology landscape has transitioned from the speculative, top line driven environment of the Zero Interest Rate Policy (ZIRP) era into an industrial phase centred on capital efficiency, clinical efficacy and regulatory defensibility. Valued at $96.68 billion in 2025, the European HealthTech sector is projected to reach $222.22 billion by 2030, representing a compound annual growth rate (CAGR) of 18.11%. Concurrently, the European MedTech sector repre